Get started
Author

Xiaoying Sun

Observed names: Sun, Xiaoying, X Y Sun
ORCID: 0009-0007-5560-2446
Observed ORCID: 0009-0007-5560-2446
OpenAlex ID: A5058679073
Shift work promotes adipogenesis via cortisol-dependent downregulation of EGR3-HDAC6 pathway
2024 · Xinxing Wan, Linghao Wang, et al. · Cell Death Discovery · 23
PDF
NAT10 promotes liver lipogenesis in mouse through N4-acetylcytidine modification of Srebf1 and Scap mRNA
2024 · Zhouqi Wang, Xinxing Wan, et al. · Lipids in Health and Disease · 22
PDF
NAT10-mediated N4-acetylcytidine modification in KLF9 mRNA promotes adipogenesis
2025 · Xinxing Wan, Linghao Wang, et al. · Cell Death and Differentiation · 17
Inetetamab combined with sirolimus and chemotherapy for the treatment of HER2‐positive metastatic breast cancer patients with abnormal activation of the PI3K/Akt/mTOR pathway after trastuzumab treatment
2024 · Qiao Li, Dan Lv, et al. · Cancer Innovation · 4
PDF
[Relationship between dynamic changes of psychological distress and quality of life in Chinese early breast cancer patients].
2022 · D Lyu, B Lan, et al. · PubMed · 3
Efficacy and safety of PARP inhibitors in metastatic breast cancer patients with homologous recombination repair pathway gene mutations: a retrospective multicenter real-world study
2026 · Xuenan Peng, Ruixia Song, et al. · Therapeutic Advances in Medical Oncology · 1
Psychological symptoms and quality of life in Chinese early-stage breast cancer patients throughout chemotherapy.
2022 · Bo Lan, Dan Lv, et al. · Journal of Clinical Oncology · 1
Abstract P4-10-14: Association between depression and anxiety status of breast cancer patients undergoing adjuvant chemotherapy and chemotherapy-induced adverse events
2022 · Dan Lv, Bo Lan, et al. · Cancer Research · 1
Abstract PO5-04-01: Inetetamab combined with sirolimus and chemotherapy in HER2 positive metastatic breast cancer patients with abnormal activation of Pi3k/Akt/mTOR pathway after trastuzumab treatment
2024 · Qiao Li, Dan Lv, et al. · Cancer Research
Clinical value of next-generation sequencing in endocrine therapy for advanced hormone receptor–positive/HER2-negative breast cancer.
2022 · Dan Lv, Binliang Liu, et al. · Journal of Clinical Oncology
Peripheral lipidomics analyses with ensemble machine learning predict response to neoadjuvant therapy in breast cancer.
2022 · Jiani Wang, Fei Ma, et al. · Journal of Clinical Oncology
Patient-reported outcomes for measuring the quality of life in advanced breast cancer treated with third-line and beyond chemotherapy-based regimens: A national cross-sectional study.
2022 · Xiuwen Guan, Xiaoyan Yan, et al. · Journal of Clinical Oncology
Works count: 13
Citation count: 72
H-index: 4
I10-index: 3
Year
Topic
Type